13
Participants
Start Date
March 29, 2021
Primary Completion Date
January 13, 2023
Study Completion Date
May 31, 2023
agenT-797
agenT-797 is an off-the-shelf cell therapy consisting of ≥ 95% allogeneic human unmodified iNKT cells isolated from 1 healthy donor mononuclear cell apheresis unit and expanded ex vivo.
Norton Cancer Institute - St. Matthews - Medical Oncology/Hematology Candida, Louisville
University of Cincinnati Cancer Center, Cincinnati
Dana-Farber Cancer Institute, Boston
Lead Sponsor
MiNK Therapeutics
INDUSTRY